4-methyl-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
Chemical Structure Depiction of
4-methyl-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
4-methyl-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide
Compound characteristics
Compound ID: | V028-0620 |
Compound Name: | 4-methyl-N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]benzamide |
Molecular Weight: | 556.71 |
Molecular Formula: | C32 H40 N6 O3 |
Salt: | not_available |
Smiles: | Cc1ccc(cc1)C(N(CCN1CCOCC1)CC(N1CCCN(CC1)c1ccc(c2ccc(C)cc2)nn1)=O)=O |
Stereo: | ACHIRAL |
logP: | 3.3637 |
logD: | 3.3305 |
logSw: | -3.1654 |
Hydrogen bond acceptors count: | 8 |
Polar surface area: | 68.966 |
InChI Key: | UKHKEAPTCFFVSZ-UHFFFAOYSA-N |